NCT05158218

Robotic Exoskeleton Gait Training in Adolescents With Cerebral Palsy

Active, enrolled NA Last updated 29 September 2025

What this trial tests

NA trial testing Robotic Exoskeleton Gait Therapy in Cerebral Palsy in 64 participants. Participants enrolled and being followed up; not accepting new ones.

Timeline

2 December 2021

Primary endpoint
1 January 2025

1 January 2026

Quick facts

Lead sponsor	Father Flanagan's Boys' Home
Phase	NA
Status	Active, enrolled
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	single
Primary purpose	treatment
Enrollment	64
Start date	2 December 2021
Primary completion	1 January 2025
Estimated completion	1 January 2026
Sites	1 location across United States

Drugs / interventions tested

• Robotic Exoskeleton Gait Therapy
• Physical Therapy

Conditions studied

• Cerebral Palsy — all drugs for Cerebral Palsy →

Sponsor

Father Flanagan's Boys' Home

Who can join

Adults 14 to 30, any sex, with Cerebral Palsy. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The study design will consist of a cohort of adolescents and young adults with cerebral palsy (CP) that will undergo a gait training protocol. All participants will complete MEG baseline brain imaging measures of their sensorimotor cortical activity, MRI brain/spinal cord imaging (previous MRI or template brain may be substituted), neurophysiological tests of the spinal cord H-reflex, and a series of mobility clinical tests.

After completing the baseline tests, the participants with CP will undergo the therapeutic gait training using either traditional physical therapy or utilizing a robotic exoskeleton. After completing all of the therapeutic gait training sessions, the participants will repeat the same assessments that were completed at baseline. The two groups will be compared based on the assessments for therapeutic outcomes.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.